CANO HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2702 USD | -0.22% |
|
+8.04% | -95.40% |
| 22/04 | First Amended Joint Reorganization and Disclosure Statement Plan Filed by Cano Health, Inc. | CI |
| 15/04 | Motion for De Minimis Asset Sale Approved for Cano Health, Inc. | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 1,157 | 1,607 | 335.1 | 16.79 |
| Enterprise Value (EV) 1 | 1,588 | 2,510 | 1,507 | 1,238 |
| P/E ratio | - | -31.5 x | -1.44 x | -0.02 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 1.39 x | 1 x | 0.12 x | 0.01 x |
| EV / Revenue | 1.91 x | 1.56 x | 0.55 x | 0.39 x |
| EV / EBITDA | 27.8 x | -47.2 x | 355 x | -3.64 x |
| EV / FCF | -4,21,46,578 x | -5,14,17,291 x | -1,28,37,566 x | 4,13,33,680 x |
| FCF Yield | -0% | -0% | -0% | 0% |
| Price to Book | - | 5.04 x | 1.22 x | -0.06 x |
| Nbr of stocks (in thousands) | 863 | 1,804 | 2,446 | 2,860 |
| Reference price 2 | 1,341 | 891.0 | 137.0 | 5.870 |
| Announcement Date | 02/04/21 | 14/03/22 | 15/03/23 | 01/04/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 231.3 | 364.4 | 829.4 | 1,609 | 2,739 | 3,138 |
| EBITDA 1 | 13.06 | 20.7 | 57.22 | -53.16 | 4.25 | -339.9 |
| EBIT 1 | 9.266 | 13.88 | 38.72 | -102.6 | -78.39 | -446 |
| Operating Margin | 4.01% | 3.81% | 4.67% | -6.38% | -2.86% | -14.21% |
| Earnings before Tax (EBT) 1 | -8.515 | -16.22 | -74.12 | -116.7 | -426.2 | -1,101 |
| Net income 1 | -8.51 | -16.12 | -74.77 | -18.02 | -207.3 | -594.4 |
| Net margin | -3.68% | -4.42% | -9.02% | -1.12% | -7.57% | -18.94% |
| EPS | - | - | - | -28.28 | -95.00 | -242.6 |
| Free Cash Flow | - | 50.83 | -37.68 | -48.81 | -117.4 | 29.94 |
| FCF margin | - | 13.95% | -4.54% | -3.03% | -4.29% | 0.95% |
| FCF Conversion (EBITDA) | - | 245.52% | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 25/01/21 | 25/01/21 | 02/04/21 | 14/03/22 | 15/03/23 | 01/04/24 |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 526.8 | 492.3 | 704.3 | 689.4 | 665 | 680.4 | 866.9 | 766.7 | 788.1 |
| EBITDA 1 | 35.16 | 11.15 | 45.01 | 29.38 | 42.45 | 35.66 | 4.979 | -149.7 | -66.09 |
| EBIT 1 | -9.635 | -42.26 | -11.46 | -31.05 | -31.44 | -39.57 | -39.53 | -245.6 | -112.9 |
| Operating Margin | -1.83% | -8.58% | -1.63% | -4.5% | -4.73% | -5.82% | -4.56% | -32.04% | -14.33% |
| Earnings before Tax (EBT) 1 | -40.34 | 1.279 | 0.995 | -13.76 | -113.3 | -300.2 | -60.58 | -272.6 | -491.8 |
| Net income 1 | -14.64 | 0.661 | 0.66 | -5.333 | -54.23 | -148.4 | -28.15 | -140.8 | -260.5 |
| Net margin | -2.78% | 0.13% | 0.09% | -0.77% | -8.15% | -21.81% | -3.25% | -18.36% | -33.05% |
| EPS 2 | -9.000 | 0.3800 | - | -3.000 | -23.00 | -61.00 | -12.00 | -51.00 | -91.87 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - |
| Announcement Date | 09/11/21 | 14/03/22 | 09/05/22 | 09/08/22 | 09/11/22 | 01/03/23 | 09/05/23 | 10/08/23 | 09/11/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 57.1 | 107 | 431 | 902 | 1,172 | 1,221 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 4.372 x | 5.166 x | 7.539 x | -16.97 x | 275.9 x | -3.591 x |
| Free Cash Flow | - | 50.8 | -37.7 | -48.8 | -117 | 29.9 |
| ROE (net income / shareholders' equity) | - | -22.5% | -95.9% | -27.5% | -66.3% | 5,397% |
| ROA (Net income/ Total Assets) | - | 3.74% | 5.1% | -4.65% | -2.41% | -18.9% |
| Assets 1 | - | -430.8 | -1,467 | 387.5 | 8,615 | 3,137 |
| Book Value Per Share | - | - | - | 177.0 | 113.0 | -97.20 |
| Cash Flow per Share | - | - | - | 90.60 | 12.20 | 21.20 |
| Capex 1 | 5.53 | 9.31 | 12.1 | 34.4 | 49.5 | 19.2 |
| Capex / Sales | 2.39% | 2.55% | 1.46% | 2.13% | 1.81% | 0.61% |
| Announcement Date | 25/01/21 | 25/01/21 | 02/04/21 | 14/03/22 | 15/03/23 | 01/04/24 |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -95.40% | 1.28M | |
| -17.07% | 16.21B | |
| +3.60% | 12.44B | |
| +5.64% | 11.58B | |
| +4.63% | 10.79B | |
| +25.36% | 8.26B | |
| -0.65% | 7.68B | |
| +22.18% | 7.06B | |
| +5.77% | 6.67B | |
| +52.00% | 4.66B |
- Stock Market
- Equities
- CANO.Q Stock
- Financials Cano Health, Inc.
